Characteristics of patients, according to transplant arm
| Characteristic . | BMT (n = 32) . | PBSCT (n = 39) . |
|---|---|---|
| Patient age, median y (range) | 42 (12-55) | 45 (23-55) |
| Donor age, median y (range) | 45 (15-61) | 43 (19-61) |
| Donor/recipient sex, no. (%) | ||
| Male/male | 12 (38) | 10 (26) |
| Male/female | 4 (13) | 7 (18) |
| Female/female | 6 (19) | 8 (21) |
| Female/male | 10 (31) | 14 (36) |
| Disease at transplantation, no. (%) | ||
| High risk* | 14 (44) | 17 (44) |
| Low risk† | 18 (56) | 22 (56) |
| Transplanted donor cells, median (range) | ||
| CD34 × 10−6/kg of recipient weight | 2.5 (1.0-4.8) | 6.9 (1.0-29.8) |
| CD3 × 10−8/kg of recipient weight | 0.2 (0.1-0.4) | 2.6 (1.7-7.9) |
| Grade of acute GVHD, no. (%) | ||
| 0 | 8 (25) | 10 (26) |
| I-II | 22 (69) | 23 (59) |
| II-IV | 2 (6) | 6 (15) |
| Follow up from transplantation, median mo (range) | 41 (26-63) | 40 (25-62) |
| Characteristic . | BMT (n = 32) . | PBSCT (n = 39) . |
|---|---|---|
| Patient age, median y (range) | 42 (12-55) | 45 (23-55) |
| Donor age, median y (range) | 45 (15-61) | 43 (19-61) |
| Donor/recipient sex, no. (%) | ||
| Male/male | 12 (38) | 10 (26) |
| Male/female | 4 (13) | 7 (18) |
| Female/female | 6 (19) | 8 (21) |
| Female/male | 10 (31) | 14 (36) |
| Disease at transplantation, no. (%) | ||
| High risk* | 14 (44) | 17 (44) |
| Low risk† | 18 (56) | 22 (56) |
| Transplanted donor cells, median (range) | ||
| CD34 × 10−6/kg of recipient weight | 2.5 (1.0-4.8) | 6.9 (1.0-29.8) |
| CD3 × 10−8/kg of recipient weight | 0.2 (0.1-0.4) | 2.6 (1.7-7.9) |
| Grade of acute GVHD, no. (%) | ||
| 0 | 8 (25) | 10 (26) |
| I-II | 22 (69) | 23 (59) |
| II-IV | 2 (6) | 6 (15) |
| Follow up from transplantation, median mo (range) | 41 (26-63) | 40 (25-62) |